Literature DB >> 11878296

Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity.

D P B McGovern, S P L Travis, J Duley, El M Shobowale-Bakre, H R Dalton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11878296     DOI： 10.1053/gast.2002.32124

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  20 in total

Review 1.  Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Authors:  Kara Bradford; David Q Shih
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 2.  Medical approaches and future options in chronic active ulcerative colitis.

Authors:  J T Siveke; C Folwaczny
Journal:  Int J Colorectal Dis       Date:  2004-01-15       Impact factor: 2.571

3.  Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.

Authors:  Javier P Gisbert; María Chaparro; Fernando Gomollón
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 4.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

5.  Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.

Authors:  Ferenc Nagy; Tamas Molnar; Zoltan Szepes; Klaudia Farkas; Tibor Nyari; Janos Lonovics
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

6.  The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Christabelle M Chen; Harpal K Marway; Sean McKeag; Charles V J Mifsud; Andrew M Pilling; Matthew J Whayman; John A Turton
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

Review 7.  Optimizing the use of thiopurines in inflammatory bowel disease.

Authors:  Rishi M Goel; Paul Blaker; Alex Mentzer; Steven C M Fong; Anthony M Marinaki; Jeremy D Sanderson
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

Review 8.  Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.

Authors:  Guillermo Gervasini; Julio Benítez; Juan Antonio Carrillo
Journal:  Eur J Clin Pharmacol       Date:  2010-06-27       Impact factor: 3.064

Review 9.  Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.

Authors:  Mehmet Coskun; Casper Steenholdt; Nanne K de Boer; Ole Haagen Nielsen
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 5.577

Review 10.  Optimizing immunomodulator therapy for inflammatory bowel disease.

Authors:  Marla C Dubinsky
Journal:  Curr Gastroenterol Rep       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.